Antimicrobial resistance of gram-negative bacilli isolated from 13 teaching hospital across China in 2018
王启,杨滨,孙自镛,梅亚宁,俞云松,廖康,郭大文,徐修礼,徐英春,胡志东,褚云卓,李轶,季萍,王辉
DOI: https://doi.org/10.3760/cma.j.cn114452-20190531-00329
2020-01-01
Abstract:Objective:To monitor the susceptibility of common used antimicrobial agents against nosocomial Gram-negative bacilli in 2018 across China.Methods:Prospective collection of Gram-negative bacilli from 13 teaching hospitals nationwide from January to December 2018. The minimal inhibitory concentration (MICs) of antibiotics such as meropenem was determined by agar dilution methods and broth microdilution methods. Interpretation of results using the Clinical and Laboratory Standards Institute(CLSI) 2019 M100S (29th Edition) standard. Data were analyzed by using WHONET-5.6 software.Results:A total of 1 214 non-repetitive Gram-negative bacilli were collected, accounting for 96.7% (1 174/1 214) of blood and sterile body fluid samples. The activity of antimicrobial agents against 871 strains of
Enterobacteriaceae was as follows in descending order of susceptible rate: amikacin (93.2%, 812/871), meropenem (92.0%, 801/871), ertapenem (88.9%, 774/871), imipenem (88.4%, 770/871), piperacillin-tazobactam (84.0%, 732/871), cefoperazone-sulbactam (83.1%, 724/871), cefepime (71.4%, 622/871), minocyline (68.9%, 600/871), ceftazidime (66.9%, 583/871), levofloxacin (54.4%, 474/871).The resistance rates of
Escherichia coli to the third generation cephalosporins were 61.5% (155/252) (ceftriaxone) and 60.7% (153/252) (cefotaxime), respectively. The resistance rates of
Klebsiella pneumoniae to the third generation cephalosporins were 56.6% (126/222) (ceftriaxone) and 57.9% (129/222) (cefotaxime), respectively. The incidence of extended-spectrum β lactamase (ESBLs) positive
E. coli and K.
pneumoniae was 50.2% (127/252) and 18.2% (40/222), respectively. Over 95% of all the ESBLs positive strains were susceptible to imipenem and meropenem. The incidence of carbapenem-resistant
Escherichia coli and
Klebsiella pneumoniae was 2.8% (7/252) and 20.4% (45/222), respectively. For
Enterobacter cloacae, Klebsiella aerogenes, Citrobacter freundii, the most susceptible agent were tigecycline (96.3%-100%), followed by amikacin (94.9%-97.1%), meropenem (89.8%-96.6%)and imipenem (89.8%-94.9%).The susceptibility of
Proteus mirabilis, Morganella morganii and
Serratia marcescens to meropenem and amikacin was over 90%.A total of 67 strains of carbapenems resistant
enterobacteriaceae(CRE) were detected. Modified carbapenem inactivation method showed, 45 strains were serine carbapenemase and 20 were metalloenzymes. The susceptibility of
Pseudomonas aeruginosa to meropenem and imipenem were 73.2% (112/153) and 66.0% (101/153), respectively.
Acinobacter baumannii has the highest sensitivity to colistin (100%, 163/163), followed by tigecycline (87.1%, 142/163).Compared with other sources of infection, specimens of bloodstream infections were less resistant to
Klebsiella pneumoniae (17.6%, 27/153
vs 21.7%, 15/69) and
Acinetobacter baumannii (68.3%, 71/104
vs 71.2%, 42/59).
Escherichia coli (2.5%,4/198
vs 0%,0/54) and
Pseudomonas aeruginosa (37%, 33/89
vs 18.8%, 12/64) have a high proportion of carbapenem resistance.
Conclusions:Carbapenems still maintain high antibacterial activity against
Enterobacteriaceae bacteria, especially strains producing only ESBLs. Carbapenem-resistant
Klebsiella pneumoniae should be given sufficient attention. Carbapenemase is the most important drug resistance mechanism of carbapenem-resistant
Enterobacteriaceae in China.